Literature DB >> 9765477

Equine endothelial cells support productive infection of equine infectious anemia virus.

W Maury1, J L Oaks, S Bradley.   

Abstract

Previous cell infectivity studies have demonstrated that the lentivirus equine infectious anemia virus (EIAV) infects tissue macrophages in vivo and in vitro. In addition, some strains of EIAV replicate to high titer in vitro in equine fibroblasts and fibroblast cell lines. Here we report a new cell type, macrovascular endothelial cells, that is infectible with EIAV. We tested the ability of EIAV to infect purified endothelial cells isolated from equine umbilical cords and renal arteries. Infectivity was detected by cell supernatant reverse transcriptase positivity, EIAV antigen positivity within individual cells, and the detection of viral RNA by in situ hybridization. Virus could rapidly spread through the endothelial cultures, and the supernatants of infected cultures contained high titers of infectious virus. There was no demonstrable cell killing in infected cultures. Three of four strains of EIAV that were tested replicated in these cultures, including MA-1, a fibroblast-tropic strain, Th.1, a macrophage-tropic strain, and WSU5, a strain that is fibroblast tropic and can cause disease. Finally, upon necropsy of a WSU5-infected horse 4 years postinfection, EIAV-positive endothelial cells were detected in outgrowths of renal artery cultures. These findings identify a new cell type that is infectible with EIAV. The role of endothelial cell infection in the course of equine infectious anemia is currently unknown, but endothelial cell infection may be involved in the edema that can be associated with infection. Furthermore, the ability of EIAV to persistently infect endothelial cultures and the presence of virus in endothelial cells from a long-term carrier suggest that this cell type can serve as a reservoir for the virus during subclinical phases of infection.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9765477      PMCID: PMC110349     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  35 in total

1.  Inability of human immunodeficiency virus to infect human microvascular endothelial cells.

Authors:  E W Ades; J K Nicholson; S W Browning; T W Comans
Journal:  Pathobiology       Date:  1992       Impact factor: 4.342

2.  Neurovirulent simian immunodeficiency virus replicates productively in endothelial cells of the central nervous system in vivo and in vitro.

Authors:  J L Mankowski; J P Spelman; H G Ressetar; J D Strandberg; J Laterra; D L Carter; J E Clements; M C Zink
Journal:  J Virol       Date:  1994-12       Impact factor: 5.103

3.  HIV-1 infection of human brain-derived microvascular endothelial cells in vitro.

Authors:  S D Poland; G P Rice; G A Dekaban
Journal:  J Acquir Immune Defic Syndr Hum Retrovirol       Date:  1995-04-15

4.  Human endothelial cells isolated from the hepatic sinusoids and the umbilical vein display a different permissiveness for HIV1.

Authors:  M E Lafon; J L Gendrault; C Royer; D Jaeck; A Kirn; A M Steffan
Journal:  Res Virol       Date:  1993 Jan-Feb

5.  Feline immunodeficiency virus can productively infect cultured endothelial cells from cat brain microvessels.

Authors:  A M Steffan; M E Lafon; J L Gendrault; F Koehren; M De Monte; C Royer; A Kirn; J P Gut
Journal:  J Gen Virol       Date:  1994-12       Impact factor: 3.891

6.  HIV infection of human choroid plexus: a possible mechanism of viral entry into the CNS.

Authors:  M F Falangola; A Hanly; B Galvao-Castro; C K Petito
Journal:  J Neuropathol Exp Neurol       Date:  1995-07       Impact factor: 3.685

7.  Antibody to ICAM-1 mediates enhancement of HIV-1 infection of human endothelial cells.

Authors:  O Scheglovitova; V Scanio; S Fais; S Papadia; I Abbate; C Castilletti; F Dianzani; M R Capobianchi
Journal:  Arch Virol       Date:  1995       Impact factor: 2.574

8.  A transformed murine myocardial vascular endothelial cell clone: characterization of cells in vitro and of tumours derived from clone in situ.

Authors:  J Plendl; F Sinowatz; R Auerbach
Journal:  Virchows Arch       Date:  1995       Impact factor: 4.064

Review 9.  HIV infection of human brain capillary endothelial cells--implications for AIDS dementia.

Authors:  A V Moses; J A Nelson
Journal:  Adv Neuroimmunol       Date:  1994

10.  Productive in vitro infection of human umbilical vein endothelial cells and three colon carcinoma cell lines with HIV-1.

Authors:  J Corbeil; L A Evans; P W McQueen; E Vasak; P D Edward; D D Richman; R Penny; D A Cooper
Journal:  Immunol Cell Biol       Date:  1995-04       Impact factor: 5.126

View more
  9 in total

1.  Characterization of a cytolytic strain of equine infectious anemia virus.

Authors:  Wendy Maury; Patrick J Wright; Sarahann Bradley
Journal:  J Virol       Date:  2003-02       Impact factor: 5.103

2.  Tissue sites of persistent infection and active replication of equine infectious anemia virus during acute disease and asymptomatic infection in experimentally infected equids.

Authors:  S M Harrold; S J Cook; R F Cook; K E Rushlow; C J Issel; R C Montelaro
Journal:  J Virol       Date:  2000-04       Impact factor: 5.103

3.  Evolution of the equine infectious anemia virus long terminal repeat during the alteration of cell tropism.

Authors:  Wendy Maury; Robert J Thompson; Quentin Jones; Sarahann Bradley; Tara Denke; Prasith Baccam; Matthew Smazik; J Lindsay Oaks
Journal:  J Virol       Date:  2005-05       Impact factor: 5.103

4.  A tumor necrosis factor receptor family protein serves as a cellular receptor for the macrophage-tropic equine lentivirus.

Authors:  Baoshan Zhang; Sha Jin; Jing Jin; Feng Li; Ronald C Montelaro
Journal:  Proc Natl Acad Sci U S A       Date:  2005-06-28       Impact factor: 11.205

5.  Horses naturally infected with EIAV harbor 2 distinct SU populations but are monophyletic with respect to IN.

Authors:  Diana T Cervantes; Judith M Ball; John Edwards; Susan Payne
Journal:  Virus Genes       Date:  2016-01-06       Impact factor: 2.332

6.  Characterization of an equine macrophage cell line: application to studies of EIAV infection.

Authors:  Isabel Fidalgo-Carvalho; Jodi K Craigo; Shannon Barnes; Carolina Costa-Ramos; Ronald C Montelaro
Journal:  Vet Microbiol       Date:  2008-11-01       Impact factor: 3.293

7.  Influence of long terminal repeat and env on the virulence phenotype of equine infectious anemia virus.

Authors:  Susan L Payne; Xiao-fang Pei; Bin Jia; Angela Fagerness; Frederick J Fuller
Journal:  J Virol       Date:  2004-03       Impact factor: 5.103

8.  Characterization of Equine Infectious Anemia Virus Long Terminal Repeat Quasispecies In Vitro and In Vivo.

Authors:  Xue-Feng Wang; Qiang Liu; Yu-Hong Wang; Shuai Wang; Jie Chen; Yue-Zhi Lin; Jian Ma; Jian-Hua Zhou; Xiaojun Wang
Journal:  J Virol       Date:  2018-03-28       Impact factor: 5.103

9.  Infection with equine infectious anemia virus vaccine strain EIAVDLV121 causes no visible histopathological lesions in target organs in association with restricted viral replication and unique cytokine response.

Authors:  Qiang Liu; Jian Ma; Xue-Feng Wang; Fei Xiao; Li-Jia Li; Jiao-Er Zhang; Yue-Zhi Lin; Cheng Du; Xi-Jun He; Xiaojun Wang; Jian-Hua Zhou
Journal:  Vet Immunol Immunopathol       Date:  2016-01-23       Impact factor: 2.046

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.